Vivosonic Inc. is a leader in the development of innovative technologies to enhance auditory evoked response detection. We are proud of our worldwide reputation for developing advanced technologies that are transforming hearing healthcare around the world.
Our flagship product is the IntegrityTM V500 System -- a unique hearing diagnostic device that provides superior and quicker response detection, better handling of myogenic artifact, and minimizes acoustic and electromagnetic interference. The product delivers timely diagnostic information in a typical clinic environment, without sedation, and without the need for special shielding equipment. Practitioners and researchers report significant advantages over conventional equipment including convenient scheduling of assessments, a reduction in wait times, more reliable testing in the NICU and OR, and improved patient safety and comfort.
AurixTM Newborn Hearing Screening System, our automated ABR system, has demonstrated practical advantages for universal newborn hearing screening programs. This includes fewer rescreens of babies who wake or stir intermittently, the ability to test high-risk babies in the NICU, and comprehensive database capabilities for reporting and follow up activities.
Vivosonic Inc. develops, manufactures and markets medical devices for hearing diagnostic measurement and newborn hearing screening. The Company is an ISO 13485 certified manufacturer with its products marketed and sold through a global distributor network in over 35 countries. The Company holds patents on proprietary algorithm techniques and the award-winning Amplitrode®. Our talented researchers and engineers are recognized in the industry for developing innovative solutions to every day clinical problems, while our Customer Support team is recognized for providing exceptional service.
The Company was incorporated in 1999 to bring to market advanced signal processing developments initiated at the University of Toronto, Institute of Biomaterials and Biomedical Engineering. We continue to evaluate new opportunities for our signal processing research and development capabilities in related fields.
120-5525 Eglinton Avenue West
Toronto, ON M9C 5K5 Canada